Ho Yeong Lim

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Jung Yong Hong · 4 shared papers, 2014–2026 · strength 1.02
   • Paper Increased risk of young-onset pancreatic cancer among adults aged 20-39 years with overweight or obesity, but not under… DOI 10.1016/j.ejca.2025.116111↗
   • Paper Threshold Dose-Response Association Between Alcohol Consumption and Risk of Young-Onset Pancreatic Cancer: A Nationwide… DOI 10.1200/jco-25-01169↗
   • Paper Prediabetes Remission and the Subsequent Risk of Pancreatic Cancer: A Nationwide Cohort Study. DOI 10.1016/j.amepre.2025.107979↗
2. Joo‐Hyun Park · 3 shared papers, 2026 · strength 0.98
   • Paper Increased risk of young-onset pancreatic cancer among adults aged 20-39 years with overweight or obesity, but not under… DOI 10.1016/j.ejca.2025.116111↗
   • Paper Threshold Dose-Response Association Between Alcohol Consumption and Risk of Young-Onset Pancreatic Cancer: A Nationwide… DOI 10.1200/jco-25-01169↗
   • Paper Prediabetes Remission and the Subsequent Risk of Pancreatic Cancer: A Nationwide Cohort Study. DOI 10.1016/j.amepre.2025.107979↗
3. Young Suk Park · 7 shared papers, 2011–2026 · strength 0.84
   • Paper Threshold Dose-Response Association Between Alcohol Consumption and Risk of Young-Onset Pancreatic Cancer: A Nationwide… DOI 10.1200/jco-25-01169↗
   • Paper Prediabetes Remission and the Subsequent Risk of Pancreatic Cancer: A Nationwide Cohort Study. DOI 10.1016/j.amepre.2025.107979↗
   • Paper Triptolide as a novel agent in pancreatic cancer: the validation using patient derived pancreatic tumor cell line. DOI 10.1186/s12885-018-4995-0↗
4. Joon Oh Park · 7 shared papers, 2011–2026 · strength 0.84
   • Paper Threshold Dose-Response Association Between Alcohol Consumption and Risk of Young-Onset Pancreatic Cancer: A Nationwide… DOI 10.1200/jco-25-01169↗
   • Paper Prediabetes Remission and the Subsequent Risk of Pancreatic Cancer: A Nationwide Cohort Study. DOI 10.1016/j.amepre.2025.107979↗
   • Paper Triptolide as a novel agent in pancreatic cancer: the validation using patient derived pancreatic tumor cell line. DOI 10.1186/s12885-018-4995-0↗
5. Kyungdo Han · 2 shared papers, 2026 · strength 0.65
   • Paper Increased risk of young-onset pancreatic cancer among adults aged 20-39 years with overweight or obesity, but not under… DOI 10.1016/j.ejca.2025.116111↗
   • Paper Prediabetes Remission and the Subsequent Risk of Pancreatic Cancer: A Nationwide Cohort Study. DOI 10.1016/j.amepre.2025.107979↗
6. Hyun‐Jin Kim · 1 shared paper, 2026 · strength 0.33
   • Paper Increased risk of young-onset pancreatic cancer among adults aged 20-39 years with overweight or obesity, but not under… DOI 10.1016/j.ejca.2025.116111↗
7. Seung Tae Kim · 3 shared papers, 2011–2018 · strength 0.13
   • Paper Triptolide as a novel agent in pancreatic cancer: the validation using patient derived pancreatic tumor cell line. DOI 10.1186/s12885-018-4995-0↗
   • Paper Safety and efficacy of adjuvant chemoradiation therapy with capecitabine after resection of pancreatic ductal adenocarc… DOI 10.1097/coc.0b013e31821a83d7↗
   • Paper Impact of KRAS mutations on clinical outcomes in pancreatic cancer patients treated with first-line gemcitabine-based c… DOI 10.1158/1535-7163.mct-11-0269↗
8. Seong Ho Choi · 2 shared papers, 2012–2014 · strength 0.06
   • Paper Randomized double-blinded, placebo-controlled phase II trial of simvastatin and gemcitabine in advanced pancreatic canc… DOI 10.1007/s00280-013-2328-1↗
   • Paper Safety and efficacy of adjuvant chemoradiation therapy with capecitabine after resection of pancreatic ductal adenocarc… DOI 10.1097/coc.0b013e31821a83d7↗
9. Kee‐Taek Jang · 2 shared papers, 2011–2012 · strength 0.05
   • Paper Safety and efficacy of adjuvant chemoradiation therapy with capecitabine after resection of pancreatic ductal adenocarc… DOI 10.1097/coc.0b013e31821a83d7↗
   • Paper Impact of KRAS mutations on clinical outcomes in pancreatic cancer patients treated with first-line gemcitabine-based c… DOI 10.1158/1535-7163.mct-11-0269↗
10. Kyu Taek Lee · 2 shared papers, 2011–2012 · strength 0.05
    • Paper Safety and efficacy of adjuvant chemoradiation therapy with capecitabine after resection of pancreatic ductal adenocarc… DOI 10.1097/coc.0b013e31821a83d7↗
    • Paper A prognostic model to predict clinical outcomes with first-line gemcitabine-based chemotherapy in advanced pancreatic c… DOI 10.1159/000328449↗
11. Jun Ho Yi · 2 shared papers, 2011 · strength 0.04
    • Paper Impact of KRAS mutations on clinical outcomes in pancreatic cancer patients treated with first-line gemcitabine-based c… DOI 10.1158/1535-7163.mct-11-0269↗
    • Paper A prognostic model to predict clinical outcomes with first-line gemcitabine-based chemotherapy in advanced pancreatic c… DOI 10.1159/000328449↗
12. Jong Kyun Lee · 1 shared paper, 2012 · strength 0.03
    • Paper Safety and efficacy of adjuvant chemoradiation therapy with capecitabine after resection of pancreatic ductal adenocarc… DOI 10.1097/coc.0b013e31821a83d7↗
13. Hee Chul Park · 1 shared paper, 2012 · strength 0.03
    • Paper Safety and efficacy of adjuvant chemoradiation therapy with capecitabine after resection of pancreatic ductal adenocarc… DOI 10.1097/coc.0b013e31821a83d7↗
14. Hye-Lim Jang · 1 shared paper, 2011 · strength 0.02
    • Paper Impact of KRAS mutations on clinical outcomes in pancreatic cancer patients treated with first-line gemcitabine-based c… DOI 10.1158/1535-7163.mct-11-0269↗
15. Dong Wook Choi · 1 shared paper, 2011 · strength 0.02
    • Paper A prognostic model to predict clinical outcomes with first-line gemcitabine-based chemotherapy in advanced pancreatic c… DOI 10.1159/000328449↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.